FDA Biologics (BLA & Biosimilars)Original article
Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application
RegulatoryNeutral
AI Analysis
Summary
FDA issues industry guidance on Chemistry, Manufacturing, and Controls flexibilities for developing human cellular and gene therapy products submitted for Biologics License Applications.
Importance:2/10
Sentiment:
0.00
CMCcellular_therapygene_therapyBLAFDA_guidancemanufacturing
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on July 7, 2026 4:25 PM